HomeDMP • FRA
add
Dermapharm Holding SE
Previous close
€37.20
Day range
€36.95 - €36.95
Year range
€29.90 - €42.15
Market cap
2.01B EUR
Avg Volume
46.00
P/E ratio
19.22
Dividend yield
2.44%
Primary exchange
ETR
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 305.26M | 1.27% |
Operating expense | 144.65M | 1.99% |
Net income | 33.40M | -23.42% |
Net profit margin | 10.94 | -24.40% |
Earnings per share | — | — |
EBITDA | 74.49M | -3.29% |
Effective tax rate | 33.16% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 115.18M | -1.86% |
Total assets | 2.11B | -2.82% |
Total liabilities | 1.47B | -7.33% |
Total equity | 642.23M | — |
Shares outstanding | 53.88M | — |
Price to book | 3.14 | — |
Return on assets | 6.51% | — |
Return on capital | 8.43% | — |
Cash Flow
Net change in cash
(EUR) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 33.40M | -23.42% |
Cash from operations | 4.23M | -87.23% |
Cash from investing | -9.30M | -38.51% |
Cash from financing | -145.00K | 99.78% |
Net change in cash | -6.11M | 85.23% |
Free cash flow | -16.03M | -474.21% |
About
Dermapharm Holding SE or Dermapharm AG, based in Grünwald, is a publicly listed German pharmaceutical company specializing in the manufacture and distribution of dermatological and allergological preparations. Wikipedia
Founded
1991
Website
Employees
3,610